Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Equity Income (2016 - 2025)

Pediatrix Medical (MD) has disclosed Equity Income for 12 consecutive years, with $843000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Income fell 8.07% to $843000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $3.6 million, a 54.99% increase, with the full-year FY2025 number at $3.6 million, up 54.99% from a year prior.
  • Equity Income was $843000.0 for Q4 2025 at Pediatrix Medical, down from $1.9 million in the prior quarter.
  • In the past five years, Equity Income ranged from a high of $1.9 million in Q3 2025 to a low of $290000.0 in Q4 2021.
  • A 5-year average of $583400.0 and a median of $492500.0 in 2021 define the central range for Equity Income.
  • Peak YoY movement for Equity Income: plummeted 42.46% in 2021, then surged 322.25% in 2025.
  • Pediatrix Medical's Equity Income stood at $290000.0 in 2021, then skyrocketed by 38.97% to $403000.0 in 2022, then increased by 18.86% to $479000.0 in 2023, then skyrocketed by 91.44% to $917000.0 in 2024, then dropped by 8.07% to $843000.0 in 2025.
  • Per Business Quant, the three most recent readings for MD's Equity Income are $843000.0 (Q4 2025), $1.9 million (Q3 2025), and $505000.0 (Q2 2025).